Written question asked by Paul Blomfield (Labour) on Monday, 22 February 2021, in the House of Commons. It was due for an answer on Wednesday, 24 February 2021. It was answered by Nadhim Zahawi (Conservative) on Friday, 5 March 2021 on behalf of the Department of Health and Social Care.
Coronavirus: Vaccination
- Question
-
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of prioritising people with ME and chronic fatigue syndrome for covid-19 vaccination.
- Answer
-
The Joint Committee on Vaccination and Immunisation (JCVI) has not identified any robust data to indicate that, as a group, persons with myalgic encephalomyelitis/chronic fatigue syndrome are at higher risk of mortality from COVID-19 and therefore are not included as a group for prioritisation for vaccination in the vaccine programme.
Prioritisation for phase two has not yet been decided, but interim advice has been published by the JVCI recommending an age-based approach which the Government has accepted in principle. Phase two of the COVID-19 vaccine programme will cover all adults under 50 not already included in Phase one.
Secondary information
- Type
- Written question
- Reference
- 156362
- Session
- 2019-21
- Subjects
- ME/CFS Vaccination Coronavirus
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2021-03-05 15:09:06 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/156362
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/156362
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/156362